NCT05196113 is a NA clinical trial of sipIT in Urolithiasis, sponsored by University of Michigan.

Who is sponsoring NCT05196113?

NCT05196113 is sponsored by University of Michigan.

What drugs are being tested in NCT05196113?

Interventions in NCT05196113: sipIT.

What condition does NCT05196113 study?

NCT05196113 studies Urolithiasis.

Is NCT05196113 still recruiting?

NCT05196113 is currently completed. Last updated 16 September 2025.

Last reviewed 2025-09-16 · How we verify

NCT05196113

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

sipIT2: Improving Adherence to Fluid Intake Guidelines for Kidney Stone Prevention

Completed NA Last updated 16 September 2025

What this trial tests

NA trial testing sipIT in Urolithiasis in 216 participants. Completed in 28 April 2025.

Timeline

4 January 2022

Primary endpoint
28 April 2025

28 April 2025

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	216
Start date	4 January 2022
Primary completion	28 April 2025
Estimated completion	28 April 2025
Sites	2 locations across United States

Drugs / interventions tested

sipIT

Conditions studied

Urolithiasis — all drugs for Urolithiasis →

Sponsor

University of Michigan

Who can join

18 and older, any sex, with Urolithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the feasibility of using sipIT tools (i.e., wrist-worn sensors, smart water bottles, mobile applications) to increase compliance with physician-recommended fluid consumption guidelines in participants with a history of urolithiasis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Promoting fluid intake to increase urine volume for kidney stone prevention: Protocol for a randomized controlled efficacy trial of the sip<sup>IT</sup> intervention.
Conroy DE, Marks J, Cutshaw A, Ram N, et al · · 2024 · cited 8× · PMID 38253254 · DOI 10.1016/j.cct.2024.107454
Machine Learning Approaches to Predict 24-Hour Urine Collection Results Based on Self-Reported Beverage Intake.
Li S, Streeper N, Ram N, Zoellner J, et al · · 2026 · PMID 41864591 · DOI 10.1053/j.jrn.2026.03.005

Verify or expand the search:

Other trials of sipIT

Trials testing the same drug.

NCT06269783 — Dual-process Mechanisms of Action for sipIT Intervention Effects in Patients With Urolithiasis · NA · completed

Other recruiting trials for Urolithiasis

Currently open trials in the same condition.

NCT07378904 — Sterile Water Injection vs Morphine for Renal Colic · NA · active not recruiting
NCT06989320 — Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease · NA · recruiting
NCT06651294 — Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments · NA · recruiting
NCT07514676 — Predictive Value of Preoperative Urine Culture for Postoperative Fever After FANS-RIRS When Surgery Proceeds Before Cult · active not recruiting
NCT06158620 — Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease · Phase 1, PHASE2 · recruiting

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05196113 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 16 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05196113.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing